» Articles » PMID: 6416850

Diabetes Mellitus, Glucose Tolerance and Insulin Response to Glucose in Patients with Primary Hyperparathyroidism Before and After Parathyroidectomy

Overview
Publisher Wiley
Specialty General Medicine
Date 1983 Oct 1
PMID 6416850
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

In a retrospectively analyzed series of 441 patients operated for primary hyperparathyroidism (HPT), the prevalence of diabetes mellitus was 8.2%, which was three times higher than in the unselected age-matched population. Following parathyroid surgery, the need for antidiabetic treatment was unchanged. The insulin response to an intravenous glucose load was enhanced preoperatively [95 mU/1 +/- 41 (SD)] in twenty-six prospectively studied patients compared to postoperative (65 +/- 41 mU/1) investigations (P less than 0.01). This response was inversely correlated (r = 2, P less than 0.01) to the serum phosphate concentrations but not related to calcium or parathyroid hormone levels. Postoperatively, most HPT patients experienced a deterioration of their glucose tolerance (t 1/2 for i.v. glucose 54 +/- 12 and 64 +/- 21 min, respectively, P less than 0.05), and one-third of them had pathological values at follow-up. Despite this, neither the fasting blood glucose levels nor the values for haemoglobin A1c were significantly affected.

Citing Articles

Parathyroid Hormone is Negatively Correlated with Glycated Hemoglobin in Newly Diagnosed Type 2 Diabetic Patients.

He X, Liu M, Ding X, Bian N, Wang J, Wang G Int J Endocrinol. 2024; 2024:8414689.

PMID: 38590929 PMC: 11001476. DOI: 10.1155/2024/8414689.


Association Between Primary Hyperparathyroidism and Secondary Diabetes Mellitus: Findings From a Scoping Review.

Barnett M Cureus. 2023; 15(6):e40743.

PMID: 37350980 PMC: 10284313. DOI: 10.7759/cureus.40743.


Primary hyperparathyroidism in young patients is associated with metabolic disorders: a prospective comparative study.

Bibik E, Dobreva E, Elfimova A, Miliutina A, Eremkina A, Gorbacheva A BMC Endocr Disord. 2023; 23(1):57.

PMID: 36890506 PMC: 9995253. DOI: 10.1186/s12902-023-01302-9.


Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism.

Kong S, Kim J, Park M, Kim S, Shin C Endocrine. 2022; 79(1):190-199.

PMID: 36220967 DOI: 10.1007/s12020-022-03211-8.


The Effects of 12-Weeks Whey Protein Supplements on Markers of Bone Turnover in Adults With Abdominal Obesity - A Analysis.

Fuglsang-Nielsen R, Rakvaag E, Vestergaard P, Hermansen K, Gregersen S, Starup-Linde J Front Endocrinol (Lausanne). 2022; 13:832897.

PMID: 35422766 PMC: 9001834. DOI: 10.3389/fendo.2022.832897.